NO932383L - Fremgangsmaate for fremstilling av nye N-derivater av (fenyletyl-beta-ol)-amin - Google Patents

Fremgangsmaate for fremstilling av nye N-derivater av (fenyletyl-beta-ol)-amin

Info

Publication number
NO932383L
NO932383L NO932383A NO932383A NO932383L NO 932383 L NO932383 L NO 932383L NO 932383 A NO932383 A NO 932383A NO 932383 A NO932383 A NO 932383A NO 932383 L NO932383 L NO 932383L
Authority
NO
Norway
Prior art keywords
phenylethyl
beta
amine
derivatives
novel
Prior art date
Application number
NO932383A
Other languages
English (en)
Other versions
NO302946B1 (no
NO932383D0 (no
Inventor
Serge Auvin
Pierre Braquet
Colette Broquet
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of NO932383D0 publication Critical patent/NO932383D0/no
Publication of NO932383L publication Critical patent/NO932383L/no
Publication of NO302946B1 publication Critical patent/NO302946B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO932383A 1992-07-17 1993-06-29 Nye N-derivater av (fenyletyl-<beta>-ol)amin NO302946B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929215274A GB9215274D0 (en) 1992-07-17 1992-07-17 Derivatives of(phenylethyl-beta-ol)amine

Publications (3)

Publication Number Publication Date
NO932383D0 NO932383D0 (no) 1993-06-29
NO932383L true NO932383L (no) 1994-01-18
NO302946B1 NO302946B1 (no) 1998-05-11

Family

ID=10718914

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932383A NO302946B1 (no) 1992-07-17 1993-06-29 Nye N-derivater av (fenyletyl-<beta>-ol)amin

Country Status (32)

Country Link
US (1) US5447942A (no)
JP (1) JP3204811B2 (no)
AT (1) AT403693B (no)
AU (1) AU672791B2 (no)
BE (1) BE1006429A3 (no)
CA (1) CA2100381C (no)
CH (1) CH687705A5 (no)
DE (1) DE4323976C2 (no)
DK (1) DK84793A (no)
DZ (1) DZ1704A1 (no)
ES (1) ES2067417B1 (no)
FI (1) FI933235A7 (no)
FR (2) FR2693723B1 (no)
GB (2) GB9215274D0 (no)
GR (1) GR1001565B (no)
HK (1) HK52596A (no)
HU (1) HUT64757A (no)
IE (1) IE73266B1 (no)
IN (1) IN183086B (no)
LU (1) LU88383A1 (no)
MA (1) MA22937A1 (no)
MY (1) MY109395A (no)
NL (1) NL9301241A (no)
NO (1) NO302946B1 (no)
NZ (1) NZ248041A (no)
OA (1) OA09838A (no)
PL (1) PL173783B1 (no)
PT (1) PT101308B (no)
RU (1) RU2060252C1 (no)
SE (1) SE503805C2 (no)
TN (1) TNSN93081A1 (no)
ZA (1) ZA934667B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006025920A2 (en) * 2004-06-19 2006-03-09 Human Biomolecular Research Institute Modulators of central nervous system neurotransmitters
WO2020148325A1 (en) 2019-01-15 2020-07-23 Phenex-Fxr Gmbh Neutral lxr modulators
GB202304652D0 (en) * 2023-03-29 2023-05-10 Atrogi Ab New compounds and medical uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700692A (en) 1971-06-04 1972-10-24 Colgate Palmolive Co 1-(4{40 -hydroxy-3{40 -(hydroxy methyl)-phenyl)-1-hydroxy-2-aralkylaminoethanes
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
AU582573B2 (en) * 1984-04-17 1989-04-06 Glaxo Group Limited Phenethanolamine compounds
DE3731198A1 (de) * 1987-02-07 1988-08-18 Bayer Ag 2-aminomethyltetrahydrofurane
JPS6485964A (en) * 1987-03-12 1989-03-30 Glaxo Group Ltd Compound
GB2230525A (en) * 1989-04-14 1990-10-24 Glaxo Group Ltd 1-(Hydroxyphenyl)-2-aminoethanol derivatives
GB2230775A (en) * 1989-04-24 1990-10-31 Glaxo Group Ltd Phenethanolamine compounds
NZ235605A (en) * 1989-10-10 1992-12-23 Glaxo Group Ltd (r)-(-)-4-hydroxy-alpha 1 -(((6-(4-phenylbutoxy)hexyl)amino)methyl)-1,3-benzenedimethanol and pharmaceutical compositions

Also Published As

Publication number Publication date
ES2067417A1 (es) 1995-03-16
FR2693723B1 (fr) 1994-10-28
LU88383A1 (fr) 1994-04-01
ES2067417B1 (es) 1995-11-16
ZA934667B (en) 1994-01-25
FI933235L (fi) 1994-01-18
DK84793D0 (da) 1993-07-16
HK52596A (en) 1996-04-03
DE4323976C2 (de) 2003-05-28
SE9302437L (sv) 1994-01-18
DK84793A (da) 1994-01-18
FI933235A7 (fi) 1994-01-18
PT101308B (pt) 1999-10-29
GB2268742B (en) 1995-11-08
SE9302437D0 (sv) 1993-07-16
SE503805C2 (sv) 1996-09-09
AU672791B2 (en) 1996-10-17
IE73266B1 (en) 1997-05-21
GR1001565B (el) 1994-05-31
RU2060252C1 (ru) 1996-05-20
TNSN93081A1 (fr) 1994-03-17
MA22937A1 (fr) 1994-04-01
AT403693B (de) 1998-04-27
NO302946B1 (no) 1998-05-11
CH687705A5 (fr) 1997-01-31
GB9314718D0 (en) 1993-08-25
DZ1704A1 (fr) 2002-02-17
PL173783B1 (pl) 1998-04-30
PT101308A (pt) 1994-05-31
HUT64757A (en) 1994-02-28
CA2100381C (en) 2004-09-21
GB9215274D0 (en) 1992-09-02
DE4323976A1 (de) 1994-01-20
IE930472A1 (en) 1994-01-26
BE1006429A3 (fr) 1994-08-23
US5447942A (en) 1995-09-05
NZ248041A (en) 1994-06-27
GB2268742A (en) 1994-01-19
NO932383D0 (no) 1993-06-29
IN183086B (no) 1999-09-04
FR2693653A1 (fr) 1994-01-21
OA09838A (fr) 1994-08-15
MY109395A (en) 1997-01-31
FI933235A0 (fi) 1993-07-16
CA2100381A1 (en) 1994-01-18
JP3204811B2 (ja) 2001-09-04
FR2693723A1 (fr) 1994-01-21
AU4204293A (en) 1994-01-20
ATA142793A (de) 1997-09-15
JPH06157492A (ja) 1994-06-03
NL9301241A (nl) 1994-02-16
HU9302057D0 (en) 1993-10-28
PL299693A1 (en) 1994-03-21
FR2693653B1 (fr) 1994-10-28

Similar Documents

Publication Publication Date Title
NO179639C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte piperidinforbindelser
NO177299C (no) Analogifremgangsmåte for fremstilling av aromatiske aminforbindelser
NO914027D0 (no) Fremgangsmaate for fremstilling av nye substituerte azetidinoner
NO178401C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-heteroaryl-triazolo-[1,5-aÅ[1,3,5Åtriaziner og -pyrazolo[2,3-aÅ[1,3,5Åtriaziner og nye mellomprodukter for fremstilling derav
FI945441A0 (fi) Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmistamiseksi
NO981431D0 (no) Fremgangsmåte for fremstilling av piperidinderivater
NO178374C (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive acetylcholinesteraseinhibitorer
FI943933A0 (fi) Menetelmä fibrinogeenireseptoriantagonistien valmistamiseksi
NO175976C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater
ITMI920134A0 (it) Procedimento migliorato per la produzione di calcourea
NO174774C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzodiazepiner
NO177712C (no) Analogifremgangsmåte for fremstilling av nye terapeutisk virksomme alkylfosfonoseriner
NO932383L (no) Fremgangsmaate for fremstilling av nye N-derivater av (fenyletyl-beta-ol)-amin
NO179101C (no) Fremgangsmåte for fremstilling av dibeskyttet 2,3-hydroksymetyl-cyklobutanol
FI943833A0 (fi) Menetelmä 2,3,5,6-tetraklooripyridiinin valmistamiseksi
NO961008L (no) Fremgangsmåte for fremstilling av cykliske cis-1-amino-2-alkanoler
FI930237A7 (fi) Menetelmä 4,6-dialkoksipyrimidiinien valmistamiseksi
FI943660A7 (fi) Menetelmä 3-karbonyyliandrostadieeni-17-karboksamidien valmistamiseksi
FI944128A0 (fi) Menetelmä N-(2-pyrimidyyli)piperatsinyyli-butyyli-imidien valmistamiseksi
NO960854D0 (no) Fremgangsmåte for fremstilling av 9-amino-1,2,3,4-tetrahydroakridiner
NO940861L (no) Fremgangsmåte for fremstilling av substituerte 2-aminoteraliner
NO932528L (no) Fremgangsmåte for fremstilling av Form 1 renitidinhydroklorid
NO963084D0 (no) Fremgangsmåte for fremstilling av pyrrolidinyl-acetamidderivater
NO952465D0 (no) Fremgangsmåte for fremstilling av aryl-kondensert- og heteraryl-kondensert-2,4-diazepin- og 2,4-diazocinforbindelser